Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of hawthorn extract WS 1442 on quality of life in NYHA II heart failure patients performing moderate endurance training
2006-004523-11Phase 4Completed
- Sponsor
- Schwabe Group
- Start
- Sep 2006
- Countries
- 1
01
Overview
Phase 4, single-arm trial of crataegus special extract WS 1442 in heart failure (HF), sponsored by Schwabe Group. Primary endpoints: Disease-specific quality of life and VO2 peak (spiroergometry on bicycle). Started Sep 2006; status: completed.
02
Drugs
crataegus special extract WS 1442
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on 2006-004523-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-004523-11.